Mariam Elmegaard
46 posts

Mariam Elmegaard
@MariamElmegaard
MD, PhD fellow @HerlevGentofte Hospital | Cardiovascular epidemiology, clinical trials and digital medicine
Copenhagen, Denmark Katılım Nisan 2022
184 Takip Edilen186 Takipçiler

I'm honored to be selected as one of the five prize recipients for the @lundbeckfonden Talent Prize. A big congratulations also goes to my mentor @TorBiering for receiving this year's Young Investigator award! @cirl
Lundbeckfonden@lundbeckfonden
Mød dette års Lundbeckfonden Young Investigator: Tor Biering-Sørensen Og dette års LF Talentprismodtagere: Amani Meaidi, Kristoffer Grundtvig Skaarup, Sia Viborg Lindskrog, Tenna Henriksen og Connar Standley James Westgate. Læs: lundbeckfonden.com/nyheder/yngre-… #talent #dkforsk #dkvid
English
Mariam Elmegaard retweetledi

New: Initiation of SGLT2 inhibitors and GLP-1 receptor agonists according to level of frailty in people with type 2 diabetes and cardiovascular disease in Denmark: a cross-sectional, nationwide study by @MariamElmegaard and colleagues thelancet.com/journals/lanhl…
English
Mariam Elmegaard retweetledi

Selvom ældre og skrøbelige patienter kan have særlig god gavn af behandling med SGLT2-hæmmere og GLP-1-receptoragonister for type-2 diabetes, hjertekarsygdom og nyresygdom, bliver de alt for sjældent startet op i behandlingerne #sundpol
buff.ly/3PSa1j4
Dansk
Mariam Elmegaard retweetledi

In this cross-sectional nationwide @LancetLongevity study @MariamElmegaard and @mortschou et al showed #frailty was associated with a ⬇️lower probability of SGLT2-inhibitor or GLP-1 receptor-agonist initiation, despite their benefits
Free 🔗 thelancet.com/journals/lanhl…

English

Så er jeg klar til #Hjertegalla i aften 💓 Glæder mig til at fejre hjerterne og nyde et fantastisk show 🤩

Dansk
Mariam Elmegaard retweetledi

👏@MariamElmegaard presented her impressive study in light of the new ESC 2023 guidelines for the management of CVD in T2D. Should we focus more on preventing cardiorenal disease in patients without established CVD and CKD 🤔? #ESCCongress @cardio_dk #DCS_ESC23 @mortschou

English
Mariam Elmegaard retweetledi

It can be difficult to discern high quality observational studies from the rest. But it is critical that we try.
Sharing some of the things I've learned here:
Bringing the Credibility Revolution to Observational Research in Cardiology | Circulation
ahajournals.org/doi/10.1161/CI…
English
Mariam Elmegaard retweetledi

Just out in European Heart Journal @ESC_Journals: 2001-2019 - CHD💔patients faced ⬆️ rates of #OHCA🧎🏻cmprd w cntrls across severities🧮. But equal 30d survival due to pre-hospital chain academic.oup.com/eurheartj/adva…
#ACHD #CVD #cardiotwitter #escardio @CopCard @ehj_ed @BarcellaCarlo
English

@MortenLamberts and his team out celebrating the funding from @Hjerteforening for the project VIR-SAAF 🫀A huge congrats! 🎊 hjerteforeningen.dk/2023/06/hjerte…

English

🎉Congratulations to @AFalkentoft on successfully defending his PhD thesis “Impact of Socioeconomics and Pharmacological Treatment Delay on Cardiovascular Mortality in Patients with Type 2 Diabetes”!🎉


English

Thrilled to have presented our research on NT-proBNP🩸 and the effects of #Afib screening🫀at the Annual Meeting for Danish Society of Cardiology #dcs2023
🗣️Our findings have also been featured in @DagensMedicinDK!
Read the article here: dagensmedicin.dk/biomarkoer-ken…


English

I ifm #HeartFailureAwarenessDays var @m_chouli , @DeewaZahir og Morten Malmborg til fredagsbøn i Stormoskéen på Nørrebro 🕌 på vegne DCS’ HF gruppe
@OscarWestin bidrog med posters
Her blev tilbudt, BT-måling og V-scan af hjertet🔉
Det var en kæmpe succes‼️
@HFA_President




Dansk

@CopCard @ClinEpidem @SebKinnberg @MortenLamberts @mortschou @NinaNouhravesh @MadsHashiba Well done @SebKinnberg 👏🏼🥇
Glostrup, Danmark 🇩🇰 English

In this @ClinEpidem paper @SebKinnberg et al found that a procedure based definition of cancer status (I.e, active and non-active) is valid in breast-, lung- and colorectal cancer ✅
dovepress.com/getfile.php?fi…

English
Mariam Elmegaard retweetledi

In this @JACCJournals sdy of >330,000 pts w DM @AndersHolt6 et al found asso between short-term NSAID use and ⬆️ w solid fill risk of HF, strongest asso in age >79 and elevated HbA1c. 😊
bit.ly/43pNbE4
#CardioTwitter

English
Mariam Elmegaard retweetledi

Nationwide, case-crossover study of >330k pts w/ #diabetes found assoc between short-term #NSAID use and risk of #HF, strongest assoc in age >79 & elevated HbA1c. Results could help physicians mitigate risk if prescribing NSAIDs for diabetes pts. bit.ly/3KutBhj #JACC

English

@m_chouli @DanielMolager @Hjerteforening @CopCard @gunngis @JarlStrange Du gjorde det fantastisk @DanielMolager 👏🏼 stort tillykke endnu engang
Dansk

Temporal trends in incidence and prognosis of #myocardialinfarction and risk prediction in #CVD in this PhD-defence by the naturally talented @DanielMolager from @Hjerteforening. What a pleasure to behold!
@CopCard #rstats #riskprediction #colliderbias




English
Mariam Elmegaard retweetledi

In this @TheLancet sdy @MariamElmegaard et al found that in 77,745 ptts w first time SGLT2-is and 56,037 GLP1-RAs the risk of discontinuing was 56% and 45%, respectively, w a decreased risk over the sdy-period
thelancet.com/journals/lanep…
#Cardiotwitter @cardiology @diabetes


English
Mariam Elmegaard retweetledi

Data on all Danish first-time users of SGLT2is and GLP1-RAs from 2013 to 2021 show that ~50% discontinued therapy within five years, but a quarter of these reinitiated therapy during the following year.
Discontinuation rates decreasing with time.
thelancet.com/journals/lanep…


English

A poem by prof. Thomas Gerds (and #ChatGPT) on why you should always include a statistician in planning an RCT 🎯 @CopCard #CardioTwitter @diskotex🥇

English


